| NCT04195555 |
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT04195555 |
Recruiting |
National Cancer Institute (NCI) |
2025-12-31 |
| NCT03698994 |
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03698994 |
Recruiting |
National Cancer Institute (NCI) |
2025-12-31 |
| NCT03526250 |
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03526250 |
Recruiting |
National Cancer Institute (NCI) |
2025-06-30 |
| NCT03449108 |
LN-145 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas |
https://ClinicalTrials.gov/show/NCT03449108 |
Recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT03635632 |
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) |
https://ClinicalTrials.gov/show/NCT03635632 |
Recruiting |
Baylor College of Medicine |
2022-06-30 |
| NCT03360760 |
Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum |
https://ClinicalTrials.gov/show/NCT03360760 |
Recruiting |
Peking University People’s Hospital |
2020-02-29 |
| NCT03359018 |
Apatinib Plus Anti-PD1 Therapy for Advanced Osteosarcoma |
https://ClinicalTrials.gov/show/NCT03359018 |
Completed |
Peking University People’s Hospital |
2019-10-22 |
| NCT03320330 |
Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT03320330 |
Active, not recruiting |
Children’s Oncology Group |
2021-09-19 |
| NCT03277924 |
Trial of Sunitinib Plus Nivolumab After Standard Treatment in Advanced Soft Tissue and Bone Sarcomas |
https://ClinicalTrials.gov/show/NCT03277924 |
Recruiting |
Grupo Espanol de Investigacion en Sarcomas |
2022-09-30 |
| NCT03244020 |
Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic Oncology |
https://ClinicalTrials.gov/show/NCT03244020 |
Enrolling by invitation |
Massachusetts General Hospital |
2023-12-31 |
| NCT03154190 |
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT03154190 |
Recruiting |
Stanford University |
2020-11-30 |
| NCT03139318 |
Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity |
https://ClinicalTrials.gov/show/NCT03139318 |
Recruiting |
University of Arkansas |
2021-06-30 |
| NCT03063983 |
Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma |
https://ClinicalTrials.gov/show/NCT03063983 |
Recruiting |
Grupo de Apoio ao Adolescente e a Crianca com Cancer |
2019-01-02 |
| NCT03013127 |
A Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery |
https://ClinicalTrials.gov/show/NCT03013127 |
Active, not recruiting |
Oslo University Hospital |
2018-11-26 |
| NCT03233204 |
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03233204 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02982941 |
Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors |
https://ClinicalTrials.gov/show/NCT02982941 |
Completed |
MacroGenics |
2019-05-22 |
| NCT02945800 |
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma |
https://ClinicalTrials.gov/show/NCT02945800 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2020-12-31 |
| NCT02856048 |
Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer |
https://ClinicalTrials.gov/show/NCT02856048 |
Active, not recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-02-28 |
| NCT03220035 |
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03220035 |
Recruiting |
National Cancer Institute (NCI) |
2023-12-31 |
| NCT02811523 |
In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma |
https://ClinicalTrials.gov/show/NCT02811523 |
Recruiting |
University Health Network, Toronto |
2024-02-29 |
| NCT03213704 |
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213704 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT03213678 |
PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213678 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02711007 |
Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy |
https://ClinicalTrials.gov/show/NCT02711007 |
Completed |
Peking University People’s Hospital |
2017-12-30 |
| NCT03213665 |
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213665 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02644460 |
Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02644460 |
Recruiting |
Emory University |
2020-12-31 |
| NCT03213652 |
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213652 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02581384 |
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors |
https://ClinicalTrials.gov/show/NCT02581384 |
Active, not recruiting |
Dana-Farber Cancer Institute |
2025-02-28 |
| NCT03210714 |
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03210714 |
Recruiting |
National Cancer Institute (NCI) |
2024-12-31 |
| NCT03155620 |
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) |
https://ClinicalTrials.gov/show/NCT03155620 |
Recruiting |
National Cancer Institute (NCI) |
2027-09-30 |
| NCT00840047 |
Methionine PET/CT Studies In Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00840047 |
Recruiting |
St. Jude Children’s Research Hospital |
2027-07-27 |
| NCT02536183 |
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02536183 |
Recruiting |
Children’s National Research Institute |
2020-10-31 |
| NCT02520128 |
A Study of IMRT in Primary Bone and Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT02520128 |
Recruiting |
University College, London |
2020-03-31 |
| NCT02517918 |
Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma |
https://ClinicalTrials.gov/show/NCT02517918 |
Recruiting |
Institut Bergonié |
2021-01-31 |
| NCT02508038 |
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors |
https://ClinicalTrials.gov/show/NCT02508038 |
Recruiting |
University of Wisconsin, Madison |
2021-05-31 |
| NCT02502786 |
Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma |
https://ClinicalTrials.gov/show/NCT02502786 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-07-31 |
| NCT02500797 |
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02500797 |
Active, not recruiting |
National Cancer Institute (NCI) |
2019-04-01 |
| NCT02487979 |
Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma |
https://ClinicalTrials.gov/show/NCT02487979 |
Completed |
National Cancer Institute (NCI) |
2017-06-30 |
| NCT02484443 |
Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma |
https://ClinicalTrials.gov/show/NCT02484443 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-03-31 |
| NCT02470091 |
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma |
https://ClinicalTrials.gov/show/NCT02470091 |
Active, not recruiting |
Children’s Oncology Group |
2019-12-31 |
| NCT02432274 |
Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma |
https://ClinicalTrials.gov/show/NCT02432274 |
Completed |
Eisai Inc. |
2019-07-31 |
| NCT02429973 |
Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma |
https://ClinicalTrials.gov/show/NCT02429973 |
Completed |
Broto, Javier MartÃn, M.D. |
2014-12-31 |
| NCT02390843 |
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors |
https://ClinicalTrials.gov/show/NCT02390843 |
Completed |
Emory University |
2019-09-22 |
| NCT02389244 |
A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas |
https://ClinicalTrials.gov/show/NCT02389244 |
Recruiting |
UNICANCER |
2022-09-30 |
| NCT02384473 |
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT02384473 |
Active, not recruiting |
University of Southern California |
2019-12-24 |
| NCT02357810 |
Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas |
https://ClinicalTrials.gov/show/NCT02357810 |
Recruiting |
Northwestern University |
2021-07-31 |
| NCT02304458 |
Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas |
https://ClinicalTrials.gov/show/NCT02304458 |
Active, not recruiting |
National Cancer Institute (NCI) |
2021-01-31 |
| NCT02301039 |
SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas |
https://ClinicalTrials.gov/show/NCT02301039 |
Active, not recruiting |
Sarcoma Alliance for Research through Collaboration |
2018-11-30 |
| NCT02243605 |
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma |
https://ClinicalTrials.gov/show/NCT02243605 |
Active, not recruiting |
National Cancer Institute (NCI) |
2019-06-30 |
| NCT02223052 |
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT02223052 |
Completed |
Celgene |
2018-06-11 |
| NCT02180867 |
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02180867 |
Active, not recruiting |
National Cancer Institute (NCI) |
2019-06-30 |
| NCT02162732 |
Molecular-Guided Therapy for Childhood Cancer |
https://ClinicalTrials.gov/show/NCT02162732 |
Active, not recruiting |
Spectrum Health Hospitals |
2020-06-30 |
| NCT02100891 |
Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors |
https://ClinicalTrials.gov/show/NCT02100891 |
Recruiting |
Medical College of Wisconsin |
2020-12-31 |
| NCT02097238 |
Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma |
https://ClinicalTrials.gov/show/NCT02097238 |
Completed |
National Cancer Institute (NCI) |
2015-06-30 |
| NCT02094625 |
NAC to Prevent Cisplatin-induced Hearing Loss |
https://ClinicalTrials.gov/show/NCT02094625 |
Recruiting |
Children’s Hospital Los Angeles |
2021-01-31 |
| NCT02076906 |
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors |
https://ClinicalTrials.gov/show/NCT02076906 |
Recruiting |
Children’s National Research Institute |
2020-10-31 |
| NCT02013336 |
Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors |
https://ClinicalTrials.gov/show/NCT02013336 |
Recruiting |
South Plains Oncology Consortium |
2020-12-31 |
| NCT01987102 |
Investigation of [6R] 5,10-methylenetetrahydrofolate as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX. |
https://ClinicalTrials.gov/show/NCT01987102 |
Completed |
Isofol Medical AB |
2017-01-03 |
| NCT01962103 |
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT01962103 |
Completed |
Celgene |
2017-12-05 |
| NCT01953900 |
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma |
https://ClinicalTrials.gov/show/NCT01953900 |
Active, not recruiting |
Baylor College of Medicine |
2021-04-30 |
| NCT04351308 |
Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma |
https://ClinicalTrials.gov/show/NCT04351308 |
Recruiting |
Peking University People’s Hospital |
2022-09-01 |
| NCT01848457 |
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy |
https://ClinicalTrials.gov/show/NCT01848457 |
Completed |
Children’s Hospital of Philadelphia |
2016-01-04 |
| NCT01833520 |
Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma |
https://ClinicalTrials.gov/show/NCT01833520 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-10-31 |
| NCT01830153 |
RAD001 in Advanced Sarcoma |
https://ClinicalTrials.gov/show/NCT01830153 |
Completed |
Asan Medical Center |
2013-01-31 |
| NCT01807468 |
Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors |
https://ClinicalTrials.gov/show/NCT01807468 |
Active, not recruiting |
Samsung Medical Center |
2015-12-31 |
| NCT01804374 |
Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma |
https://ClinicalTrials.gov/show/NCT01804374 |
Completed |
Italian Sarcoma Group |
2014-12-31 |
| NCT01803152 |
Dendritic Cell Vaccine for Children and Adults With Sarcoma |
https://ClinicalTrials.gov/show/NCT01803152 |
Active, not recruiting |
University of Miami |
2019-09-10 |
| NCT01674101 |
Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy |
https://ClinicalTrials.gov/show/NCT01674101 |
Completed |
St. Jude Children’s Research Hospital |
2015-11-30 |
| NCT01669369 |
Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma |
https://ClinicalTrials.gov/show/NCT01669369 |
Recruiting |
Sun Yat-sen University |
2023-12-31 |
| NCT01661400 |
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors |
https://ClinicalTrials.gov/show/NCT01661400 |
Recruiting |
Washington University School of Medicine |
2022-11-23 |
| NCT01650090 |
Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma |
https://ClinicalTrials.gov/show/NCT01650090 |
Completed |
Eleison Pharmaceuticals LLC. |
2018-11-30 |
| NCT01614795 |
Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma |
https://ClinicalTrials.gov/show/NCT01614795 |
Completed |
National Cancer Institute (NCI) |
2014-04-01 |
| NCT01590069 |
Aerosolized Aldesleukin in Treating Patients With Lung Metastases |
https://ClinicalTrials.gov/show/NCT01590069 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-06-30 |
| NCT01588522 |
Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease |
https://ClinicalTrials.gov/show/NCT01588522 |
Completed |
Berg, LLC |
2017-01-31 |
| NCT01553539 |
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT01553539 |
Completed |
Wake Forest University Health Sciences |
2013-01-31 |
| NCT01532687 |
Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT01532687 |
Active, not recruiting |
OHSU Knight Cancer Institute |
2020-06-30 |
| NCT01518413 |
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT01518413 |
Completed |
Children’s National Research Institute |
2015-01-31 |
| NCT01459484 |
ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma |
https://ClinicalTrials.gov/show/NCT01459484 |
Active, not recruiting |
Italian Sarcoma Group |
2021-03-31 |
| NCT01353625 |
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. |
https://ClinicalTrials.gov/show/NCT01353625 |
Active, not recruiting |
Celgene |
2020-12-28 |
| NCT01336803 |
Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI |
https://ClinicalTrials.gov/show/NCT01336803 |
Completed |
Stanford University |
2014-07-31 |
| NCT04294511 |
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma |
https://ClinicalTrials.gov/show/NCT04294511 |
Recruiting |
Sun Yat-sen University |
2021-03-16 |
| NCT04183062 |
BIO-11006 for Osteosarcoma and Ewing’s Sarcoma Lung Metastases |
https://ClinicalTrials.gov/show/NCT04183062 |
Recruiting |
Nicklaus Children’s Hospital f/k/a Miami Children’s Hospital |
2022-11-04 |
| NCT04154189 |
A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma |
https://ClinicalTrials.gov/show/NCT04154189 |
Recruiting |
Eisai Inc. |
2022-12-31 |
| NCT04040205 |
Abemaciclib for Treatment of Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration |
https://ClinicalTrials.gov/show/NCT04040205 |
Recruiting |
Medical College of Wisconsin |
2023-09-01 |
| NCT03960177 |
Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma |
https://ClinicalTrials.gov/show/NCT03960177 |
Recruiting |
OHSU Knight Cancer Institute |
2020-10-01 |
| NCT03932071 |
Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma |
https://ClinicalTrials.gov/show/NCT03932071 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2020-01-01 |
| NCT03909776 |
Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity Osteosarcoma |
https://ClinicalTrials.gov/show/NCT03909776 |
Completed |
Peking University People’s Hospital |
2019-04-01 |
| NCT03900793 |
Losartan + Sunitinib in Treatment of Osteosarcoma |
https://ClinicalTrials.gov/show/NCT03900793 |
Recruiting |
University of Colorado, Denver |
2024-02-29 |
| NCT03860207 |
Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers |
https://ClinicalTrials.gov/show/NCT03860207 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-02-28 |
| NCT03718091 |
M6620 (VX-970) in Selected Solid Tumors |
https://ClinicalTrials.gov/show/NCT03718091 |
Recruiting |
Massachusetts General Hospital |
2022-04-30 |
| NCT03676985 |
A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma |
https://ClinicalTrials.gov/show/NCT03676985 |
Recruiting |
Lee’s Pharmaceutical Limited |
2020-02-14 |
| NCT03643133 |
Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients |
https://ClinicalTrials.gov/show/NCT03643133 |
Recruiting |
UNICANCER |
2022-10-31 |
| NCT03628209 |
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma |
https://ClinicalTrials.gov/show/NCT03628209 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2021-07-31 |
| NCT03618381 |
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults |
https://ClinicalTrials.gov/show/NCT03618381 |
Recruiting |
Seattle Children’s Hospital |
2021-06-30 |
| NCT03598595 |
Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma |
https://ClinicalTrials.gov/show/NCT03598595 |
Recruiting |
M.D. Anderson Cancer Center |
2022-03-02 |
| NCT03496402 |
Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) |
https://ClinicalTrials.gov/show/NCT03496402 |
Recruiting |
Institut Curie |
2025-04-01 |
| NCT03478462 |
Dose Escalation Study of CLR 131 in Children and Adolescents With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma |
https://ClinicalTrials.gov/show/NCT03478462 |
Recruiting |
Cellectar Biosciences, Inc. |
2020-09-30 |
| NCT03462316 |
NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma |
https://ClinicalTrials.gov/show/NCT03462316 |
Recruiting |
Sun Yat-sen University |
2020-10-20 |
| NCT03449901 |
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing’s Sarcoma, and Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03449901 |
Recruiting |
Washington University School of Medicine |
2021-05-09 |
| NCT03425279 |
CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT03425279 |
Recruiting |
BioAtla, LLC |
2022-01-31 |
| NCT01241162 |
Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma |
https://ClinicalTrials.gov/show/NCT01241162 |
Completed |
University of Louisville |
2016-10-31 |
| NCT01176981 |
Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma |
https://ClinicalTrials.gov/show/NCT01176981 |
Completed |
The Hospital for Sick Children |
2016-10-31 |
| NCT01154816 |
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia |
https://ClinicalTrials.gov/show/NCT01154816 |
Completed |
Children’s Oncology Group |
2015-12-31 |
| NCT01154452 |
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma |
https://ClinicalTrials.gov/show/NCT01154452 |
Completed |
National Cancer Institute (NCI) |
2015-02-28 |
| NCT01091883 |
Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT01091883 |
Completed |
InSightec |
2019-01-31 |
| NCT01085565 |
Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System |
https://ClinicalTrials.gov/show/NCT01085565 |
Completed |
InSightec |
2013-03-31 |
| NCT01016015 |
Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma |
https://ClinicalTrials.gov/show/NCT01016015 |
Completed |
National Cancer Institute (NCI) |
2014-07-31 |
| NCT01005043 |
Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma |
https://ClinicalTrials.gov/show/NCT01005043 |
Completed |
University Hospital Heidelberg |
2018-08-01 |
| NCT00978471 |
Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00978471 |
Completed |
Centre Leon Berard |
2018-10-29 |
| NCT00931931 |
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors |
https://ClinicalTrials.gov/show/NCT00931931 |
Completed |
Nationwide Children’s Hospital |
2018-03-19 |
| NCT00889057 |
Sorafenib in Relapsed High Grade Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00889057 |
Completed |
Italian Sarcoma Group |
2010-12-31 |
| NCT00831844 |
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00831844 |
Completed |
National Cancer Institute (NCI) |
2013-04-30 |
| NCT03742193 |
Pulmonary Resectable Metastases of Osteosarcoma With Apatinib and CHemotherapy |
https://ClinicalTrials.gov/show/NCT03742193 |
Recruiting |
Ruijin Hospital |
2022-04-01 |
| NCT03006848 |
A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma |
https://ClinicalTrials.gov/show/NCT03006848 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2020-03-18 |
| NCT01331135 |
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors |
https://ClinicalTrials.gov/show/NCT01331135 |
Completed |
Emory University |
2017-08-09 |
| NCT02880319 |
Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone |
https://ClinicalTrials.gov/show/NCT02880319 |
Recruiting |
Dana-Farber Cancer Institute |
2021-05-31 |
| NCT02867592 |
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors |
https://ClinicalTrials.gov/show/NCT02867592 |
Recruiting |
National Cancer Institute (NCI) |
2020-09-30 |
| NCT00802880 |
Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma |
https://ClinicalTrials.gov/show/NCT00802880 |
Completed |
Washington University School of Medicine |
2015-01-31 |
| NCT02107963 |
A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors |
https://ClinicalTrials.gov/show/NCT02107963 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-08-15 |
| NCT02048371 |
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes |
https://ClinicalTrials.gov/show/NCT02048371 |
Recruiting |
Sarcoma Alliance for Research through Collaboration |
2021-08-31 |
| NCT02415816 |
Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas |
https://ClinicalTrials.gov/show/NCT02415816 |
Recruiting |
St. Jude Children’s Research Hospital |
2022-03-31 |
| NCT04055220 |
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas |
https://ClinicalTrials.gov/show/NCT04055220 |
Recruiting |
Centre Leon Berard |
2024-10-01 |
| NCT00743509 |
A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma |
https://ClinicalTrials.gov/show/NCT00743509 |
Completed |
University of Michigan Rogel Cancer Center |
2010-04-30 |
| NCT00743496 |
A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma |
https://ClinicalTrials.gov/show/NCT00743496 |
Completed |
St. Jude Children’s Research Hospital |
2014-04-01 |
| NCT00742924 |
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00742924 |
Completed |
Children’s Oncology Group |
2012-04-30 |
| NCT00720174 |
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00720174 |
Completed |
National Cancer Institute (NCI) |
2013-01-31 |
| NCT00716976 |
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy |
https://ClinicalTrials.gov/show/NCT00716976 |
Completed |
Children’s Oncology Group |
2015-04-30 |
| NCT00667342 |
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00667342 |
Completed |
St. Jude Children’s Research Hospital |
2014-08-31 |
| NCT00645632 |
Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00645632 |
Completed |
Mayo Clinic |
1995-01-31 |
| NCT00634504 |
Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze |
https://ClinicalTrials.gov/show/NCT00634504 |
Completed |
BTG International Inc. |
2009-08-31 |
| NCT00592293 |
Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas |
https://ClinicalTrials.gov/show/NCT00592293 |
Active, not recruiting |
Massachusetts General Hospital |
2021-09-30 |
| NCT00586846 |
Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00586846 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-02-28 |
| NCT00580385 |
Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors |
https://ClinicalTrials.gov/show/NCT00580385 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-08-31 |
| NCT00572130 |
Phase II Study of Intravenous Rexin-G in Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00572130 |
Completed |
Epeius Biotechnologies |
2010-07-31 |
| NCT00538239 |
Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6) |
https://ClinicalTrials.gov/show/NCT00538239 |
Completed |
Merck Sharp & Dohme Corp. |
2010-10-31 |
| NCT00523419 |
Chemotherapy for Patients With Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00523419 |
Completed |
Eli Lilly and Company |
2009-06-30 |
| NCT00520936 |
A Study of Pemetrexed in Children With Recurrent Cancer |
https://ClinicalTrials.gov/show/NCT00520936 |
Completed |
Eli Lilly and Company |
2010-02-28 |
| NCT00504140 |
Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00504140 |
Completed |
M.D. Anderson Cancer Center |
2007-11-30 |
| NCT00503295 |
Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung |
https://ClinicalTrials.gov/show/NCT00503295 |
Completed |
Oncolytics Biotech |
2011-02-28 |
| NCT00470223 |
Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00470223 |
Active, not recruiting |
UNICANCER |
2015-12-31 |
| NCT00020267 |
Vaccine Therapy in Treating Patients With Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00020267 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019630 |
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00019630 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00407433 |
Clinical Studies of Gemcitabine-Oxaliplatin |
https://ClinicalTrials.gov/show/NCT00407433 |
Completed |
Gustave Roussy, Cancer Campus, Grand Paris |
NA |
| NCT00331643 |
Ixabepilone in Treating Young Patients With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00331643 |
Completed |
National Cancer Institute (NCI) |
2007-10-31 |
| NCT00330421 |
Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) |
https://ClinicalTrials.gov/show/NCT00330421 |
Completed |
National Cancer Institute (NCI) |
2007-12-31 |
| NCT00245011 |
Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00245011 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2008-10-31 |
| NCT00187109 |
Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy |
https://ClinicalTrials.gov/show/NCT00187109 |
Completed |
St. Jude Children’s Research Hospital |
2007-02-28 |
| NCT00180908 |
Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children |
https://ClinicalTrials.gov/show/NCT00180908 |
Completed |
Gustave Roussy, Cancer Campus, Grand Paris |
NA |
| NCT00145639 |
Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00145639 |
Completed |
St. Jude Children’s Research Hospital |
2006-05-31 |
| NCT00132158 |
ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00132158 |
Completed |
St. Jude Children’s Research Hospital |
2011-10-31 |
| NCT00119301 |
Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00119301 |
Completed |
Memorial Sloan Kettering Cancer Center |
2007-04-30 |
| NCT00112463 |
Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00112463 |
Completed |
National Cancer Institute (NCI) |
2008-10-23 |
| NCT00102531 |
Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung |
https://ClinicalTrials.gov/show/NCT00102531 |
Completed |
Insmed Incorporated |
2008-03-31 |
| NCT00101270 |
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00101270 |
Completed |
National Cancer Institute (NCI) |
2007-09-30 |
| NCT00093821 |
Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors |
https://ClinicalTrials.gov/show/NCT00093821 |
Completed |
National Cancer Institute (NCI) |
2007-08-31 |
| NCT00093080 |
Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00093080 |
Completed |
Merck Sharp & Dohme Corp. |
2008-11-30 |
| NCT00091182 |
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment |
https://ClinicalTrials.gov/show/NCT00091182 |
Completed |
National Cancer Institute (NCI) |
2006-02-28 |
| NCT00003776 |
Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00003776 |
Completed |
Memorial Sloan Kettering Cancer Center |
2000-03-31 |
| NCT00005625 |
Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00005625 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-09-30 |
| NCT00077454 |
Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00077454 |
Completed |
National Cancer Institute (NCI) |
2007-09-30 |
| NCT00003937 |
Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00003937 |
Completed |
Children’s Oncology Group |
2004-03-31 |
| NCT00073983 |
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing’s Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma |
https://ClinicalTrials.gov/show/NCT00073983 |
Completed |
Sarcoma Alliance for Research through Collaboration |
2010-01-31 |
| NCT00066365 |
Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00066365 |
Completed |
Children’s Oncology Group |
2010-07-31 |
| NCT00030667 |
Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood |
https://ClinicalTrials.gov/show/NCT00030667 |
Completed |
National Cancer Institute (NCI) |
2005-12-31 |
| NCT00002539 |
Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00002539 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2002-10-31 |
| NCT00004078 |
Irinotecan in Treating Children With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00004078 |
Completed |
Children’s Oncology Group |
2007-10-31 |
| NCT00031915 |
Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma |
https://ClinicalTrials.gov/show/NCT00031915 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00023998 |
Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00023998 |
Completed |
National Cancer Institute (NCI) |
2005-11-30 |
| NCT00012181 |
Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00012181 |
Completed |
National Cancer Institute (NCI) |
2005-01-31 |
| NCT00005033 |
Trastuzumab in Treating Patients With Recurrent Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00005033 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00004241 |
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma |
https://ClinicalTrials.gov/show/NCT00004241 |
Completed |
National Cancer Institute (NCI) |
2006-05-31 |
| NCT00001436 |
A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma |
https://ClinicalTrials.gov/show/NCT00001436 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001217 |
Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study |
https://ClinicalTrials.gov/show/NCT00001217 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001209 |
A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors |
https://ClinicalTrials.gov/show/NCT00001209 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00038207 |
Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies |
https://ClinicalTrials.gov/show/NCT00038207 |
Completed |
M.D. Anderson Cancer Center |
2004-09-30 |